This installment of the "Profiles in Innovation" series features
Alfred Mann, the Chairman of the Board and CEO of MannKind Corporation, a diversified biopharmaceutical company that develops novel therapeutics for diabetes, cancer autoimmune and inflammatory diseases. (#11117)